Interleukin-6 expression and its modulation by diacerein in a rat model of chronic stress induced cardiac dysfunction

Vipul Agarwal1, Arjun Singh Kaushik1, Mujeeba Rehman1

  • 1Department of Pharmaceutical Sciences, Babasaheb Bhimrao Ambedkar University, Vidya Vihar, Raebareli Road, Lucknow, 226025, UP, India.

Heliyon
|December 17, 2021
PubMed

Insights

Chronic stress increases inflammation and cardiovascular disease risk. Diacerein, an IL-6 modulator, prevented stress-induced heart dysfunction in rats, suggesting its potential for preventing stress-related cardiovascular issues.

Area of Science:

  • Cardiovascular Pharmacology
  • Stress Physiology
  • Immunology

Background:

  • Chronic stress elevates pro-inflammatory cytokines, increasing cardiovascular disease susceptibility.
  • Interleukin-6 (IL-6) is implicated in stress-related inflammation and cardiovascular dysfunction.
  • The therapeutic potential of diacerein, an IL-6 modulator, in stress-induced cardiovascular diseases remains unassessed.

Purpose of the Study:

  • To establish a rat model of chronic unpredictable stress (CUS) exhibiting cardiovascular dysfunction.
  • To evaluate the efficacy of diacerein in mitigating cardiovascular impairments in CUS-exposed rats.
  • To investigate the molecular interaction between diacerein and the IL-6 pathway.

Main Methods:

  • Male Wistar rats were subjected to 8 weeks of CUS to induce stress and cardiovascular changes.
  • Molecular docking (AutoDock, SwissDock) assessed diacerein's binding affinity to the IL-6 receptor.
  • Diacerein (50 mg/kg/day) was administered post-CUS; serum IL-6 levels (ELISA) and heart function (ECG-HRV) were analyzed.

Main Results:

  • CUS exposure significantly increased serum corticosterone and IL-6 levels (two-fold).
  • ECG-HRV analysis revealed altered heart rhythm, elevated heart rate, blood pressure, and sympathetic tone in CUS rats.
  • Molecular docking confirmed high binding affinity of diacerein to the IL-6 receptor.
  • Diacerein treatment effectively prevented CUS-induced cardiovascular dysfunctions.

Conclusions:

  • Interleukin-6 plays a significant role in chronic stress-induced cardiovascular dysfunctions.
  • Diacerein demonstrates potential as a preventive therapeutic agent for stress-related cardiovascular conditions.
  • Targeting the IL-6 pathway with diacerein may offer a novel strategy for managing stress-induced cardiovascular risks.